Case File
efta-efta00953914DOJ Data Set 9OtherFrom: Jeffrey Epstein [email protected]>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00953914
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein [email protected]>
To: 'Barrett, Paul S" caz•
Subject: Re: NEW HY RMBS BWIC - S4.3mm of RFMSI 0444 IMI Qa 85-16 (6.51% yield/2.97 dum)
Date: Mon, 11 Feb 2013 17:37:45 +0000
ok
On Mon, Feb II, 2013 at 1:07 PM, Barrett, Paul S na.
wrote:
lehey
We should buy SLIAM al this bond.
US Onshore aents - Blue SAy (US. State securities taw): Please confirm Woe Sky eholbility before sandtMo to a US Onshore client by entering the CUSIP Into the web tool located or; Weliacopil.ometyparchase.net.SOSO/BloeSAyPoge.html anti review to see If
your client's state of residence Is Akre . If you receive WO SIGNOR), FOLINO;110 STATES FOUND' or the :county DOES NOT HAVE A CUSIP arts not USadenominated, then please contact you 514 or local compliance officer and provide the requested sectrnIty anti
them information. Please note that a sultablity review and other amitotic procedures must :la be/allowed.
THE BOND'
The RFMSI 04-541M1 is a Prime Seasoned Fix 5.25% Sub bond backed by 105 months seaszymi flunstagna. The bond has 2.38% credit enhancement vs 7.08% 604 delinquencies, for a 0 Mx coverage/alio.
THE COI LATERAL.
The pool consists of 145 Prime loans that are 105 months seasoned with an average updated LTV of 56%. The average balance of the loans Is $296k - this coupled with the low updated LTV should result in both low
CDRs and Severities. In fact, there has been only 2 CDR prints over the last 12 months and the average severity of those 2 prints is 20.64%. Our base case assumes 35% severity ramping down to 30% over 3 years.
What's more interesting is that the S foreclosure loans in the pipe have an updated LTV of 41%, which is even lower than the overall pool LTV of 56%. According to our model, this should translate to lower seventies
at liquidation.
THE STORY:
for investors looking for a housing recovery play backed by seasoned Prime collateral, this bond offers a great convexity story levered to prepayments and overall homeowner performance.
Please call the desk with all bids/Inquiries related to this bond. X32124
HIGHLIGHTS
11P1 Updated LTV a 56%
87% of the borrowers have not missed a payment in the past 2 years
105 months seasoned
735 FICO
5296k average balance
"Source: Bloomberg
RFMSI 200444 1MI Offered 684516
ROM DESCRIPTION
prep.", 5z.xo
20 CPR
24 CPR
28 CPR
Cusp
7611001M
Cetaut liLlik
2 ramp 2043 raw 12 2CDR
2 ramp 2043 ramp 33 1.75 CCR
2 romp 2043 tamp 12 1 5 CDR
Orient Face
4314.300
Detail Seeerily
40 MVO 36 36
36 HMO 36 30
30
Cunene Face
2092.760
COrq Rule
7.4P•itent
7.4Percee4
7.5 Pwoeni
Bons 1)eo
RaIlf9S iSI(PASoodys.FICh)
Pomo Fa 5.28% Mau
occeow
Der., Aevanco %of.]
100
100
100
Curren! Cetcon
.
5 29"
Ylall di Base Casa
6.9:0%
Me 1!8115.15
WAS. *Base Case
4.03
Yield
2.124
6103
9.815
Principal Woclow 6 Base Case
meralo 0037
Spread over Tey
138
575
912
Wrirgdoen %
14436%
Ouneren
3.18
2.97
2.71
Curren, Croat Eltiatiallril
21S%
VIAL
4.05
4.03
3.84
03. Ctinquencel
708
Ponape Wroclaw
1.18031o141036
lerol3 to 0037
Mer13 Is 0037
W. Coanauoncr Comeaae
0.34x
Principal Maclean
2922%
1446%
3.28%
This Cereal Loss
OW%
0.46%
0.39%
UNDERLYING COLLATERAL OESCRIPTION
Total Usvidalian
7.69%
683%
5.55%
'Verne Loan Ostoncv (5,00%)
296
Loan Cowl
145
1 NOS
38i013
e mos
klorts.35 Tura
Seasoned Prime 304 Ax
%WA., MoraaVe Coupon
5665%
CPR
2723
31 87
274$
wss Ave FICO Score
735
COR
0.00
1.64
220
‘vgi Ave Cvg Lcen.to.Vathe
6181%
BEV
NA
30.01
30.01
HPIA4 LTv
5615%
Meolled An; Lorna/J.,
Pan** Oc.a.sied
lip I GcoCo5ccetaban
lip 2 GcoCo5ccetaban
105
95.17
CA49%
IX 7%
TW 3 C059 Conorhoran
NY 5%
Nwa..0 Cyreet (24 inns)
0581%
EFTA00953914
IMPORTANT DISCUUMER:
Nothagency RMBS is a complex fixed income product and is not suitable for all investors. Please note that while desk assumptions are driven by a number of collateral and macro factors, the historical performance of a deal is not indicative of
its future performance. Additionally, this message is a product of sales and trading and is not a research report. Other key risks to consider are outhned below:
All investments are subject to possible loss of principal
Non-Agency bonds may have limited liquidity and clients should be aware that the secondary market for mortgage-bathed securities has experienced periods of illiquidity and may do so in the future. 'liquidity means that there may not be
any purchasers for your class of certificates. Although any dais of certificates may experience illiquidity, it is more likely that classes that are lower in the capital structure and non-investment grade related may experience greater illiquidity than
more senior, investment-grade rated dames.
-
High Yield tionagency bonds are speculative non-investment grade bonds that have higher risk of default or other adverse credit events which are appropriate for high risk investors only
Non.Agency bonds are intended for diems with a minimum total net worth of $SOmai. Please make sure your client fulfills this requirement before soliciting this order.
This commentary is a product of theAorgan Global Wealth Managements Taxable Fixed Income Trading Desk and not eMorgan's Research Department. The views expressed in this trading des* oammemary may differ from those of AxMorgan's Research Department. Any
opinions cm:vexed rites trading desk commentary are suNect to change without notice and eMorgan is wider noobligati:di to update or keep this information current.
fm„.m. Banana immp igt ota j., no
GOA \Agin lAnnAntn"
270 On. kerne, Fba 5, nen Yon hem vul, 1))17
This anal 350,566cm°' and sunontenmyortny Aida:nun and condoms uncluing on ortas Srihrpnrctwe 01 sale of KaIltIO. accuracy al conelttaten of infontsnonst vinivn. neon& whin. tent pflncyc. and ley] alloy
brap,
yy
m
4oln ir chAlm
,synneal
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by c-mail to jrevacationCit,grnalEgm, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
irtxts..nili
al
EFTA00953915
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
weliacopil.ometyparchase.netEmail
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.